These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24831421)

  • 1. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study.
    Farrar JT; Troxel AB; Haynes K; Gilron I; Kerns RD; Katz NP; Rappaport BA; Rowbotham MC; Tierney AM; Turk DC; Dworkin RH
    Pain; 2014 Aug; 155(8):1622-1631. PubMed ID: 24831421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
    Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M
    Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.
    Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J
    BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin for Chronic Neuropathic Pain.
    Moore A; Derry S; Wiffen P
    JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
    Vinik A; Emir B; Parsons B; Cheung R
    Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
    Liedgens H; Hertel N; Gabriel A; Nuijten M; Dakin H; Mitchell S; Nautrup BP
    Clin Drug Investig; 2008; 28(9):583-601. PubMed ID: 18666805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
    Vinik A; Emir B; Cheung R; Whalen E
    Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.